Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Perkins

Showing results (331-340 of 340) with videos related to

Pageof 34
Sort By:
You have reached the last page of results.This site can display upto 340 results.
Journal of Medicinal Chemistry|August 24, 2000
Selective cyclooxygenase-2 inhibitors: heteroaryl modified 1,2-diarylimidazoles are potent, orally active antiinflammatory agentsI K Khanna, Y Yu, R M Huff, et al.
Journal of Medicinal Chemistry|January 5, 1996
Diarylspiro[2.4]heptenes as orally active, highly selective cyclooxygenase-2 inhibitors: synthesis and structure-activity relationshipsH C Huang, J J Li, D J Garland, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 25, 2024
The Association of Asthma and Metabolic Dysfunction With Outcomes of Hospitalized Patients With COVID-19Marija Vukoja, Aysun Tekin, Nereida A Parada, et al.
JACC. Cardiovascular Interventions|May 25, 2013
Intracoronary optical coherence tomography and histology of overlapping everolimus-eluting bioresorbable vascular scaffolds in a porcine coronary artery model: the potential implications for clinical practiceVasim Farooq, Patrick W Serruys, Jung Ho Heo, et al.
Critical Care Medicine|July 27, 2022
Association of Renin Angiotensin Aldosterone System Inhibitors and Outcomes of Hospitalized Patients With COVID-19Neha Gupta, Lisa Settle, Brent R Brown, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 9, 2014
Tumorgrafts as in vivo surrogates for women with ovarian cancerS John Weroha, Marc A Becker, Sergio Enderica-Gonzalez, et al.
Ecology|July 18, 2013
Do invasive species perform better in their new ranges?John D Parker, Mark E Torchin, Ruth A Hufbauer, et al.
Journal of Medicinal Chemistry|April 25, 1997
Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benze nesulfonamide (SC-58635, celecoxib)T D Penning, J J Talley, S R Bertenshaw, et al.
Brain Communications|March 27, 2023
Cognitive correlates of antisaccade behaviour across multiple neurodegenerative diseasesHeidi C Riek, Donald C Brien, Brian C Coe, et al.
Climatic Change|September 19, 2025
The attribution of human health outcomes to climate change: a transdisciplinary guidance documentK Ebi, A Haines, R F S Andrade, et al.
Pageof 34

Showing results (331-340 of 340) with videos related to

Sort By:
Pageof 34
You have reached the last page of results.This site can display upto 340 results.
Journal of Medicinal Chemistry|August 24, 2000
Selective cyclooxygenase-2 inhibitors: heteroaryl modified 1,2-diarylimidazoles are potent, orally active antiinflammatory agentsI K Khanna, Y Yu, R M Huff, et al.
Journal of Medicinal Chemistry|January 5, 1996
Diarylspiro[2.4]heptenes as orally active, highly selective cyclooxygenase-2 inhibitors: synthesis and structure-activity relationshipsH C Huang, J J Li, D J Garland, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 25, 2024
The Association of Asthma and Metabolic Dysfunction With Outcomes of Hospitalized Patients With COVID-19Marija Vukoja, Aysun Tekin, Nereida A Parada, et al.
JACC. Cardiovascular Interventions|May 25, 2013
Intracoronary optical coherence tomography and histology of overlapping everolimus-eluting bioresorbable vascular scaffolds in a porcine coronary artery model: the potential implications for clinical practiceVasim Farooq, Patrick W Serruys, Jung Ho Heo, et al.
Critical Care Medicine|July 27, 2022
Association of Renin Angiotensin Aldosterone System Inhibitors and Outcomes of Hospitalized Patients With COVID-19Neha Gupta, Lisa Settle, Brent R Brown, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 9, 2014
Tumorgrafts as in vivo surrogates for women with ovarian cancerS John Weroha, Marc A Becker, Sergio Enderica-Gonzalez, et al.
Ecology|July 18, 2013
Do invasive species perform better in their new ranges?John D Parker, Mark E Torchin, Ruth A Hufbauer, et al.
Journal of Medicinal Chemistry|April 25, 1997
Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benze nesulfonamide (SC-58635, celecoxib)T D Penning, J J Talley, S R Bertenshaw, et al.
Brain Communications|March 27, 2023
Cognitive correlates of antisaccade behaviour across multiple neurodegenerative diseasesHeidi C Riek, Donald C Brien, Brian C Coe, et al.
Climatic Change|September 19, 2025
The attribution of human health outcomes to climate change: a transdisciplinary guidance documentK Ebi, A Haines, R F S Andrade, et al.
Pageof 34